Guidance released by the Utah Department of Health can be found by following this link

• Clinicians are advised to initiate antiviral therapy immediately on all patients with influenza-like illness who are hospitalized or who are at higher risk of complications.  For information on high risk groups, please visit the website above.
• Hospitalized cases and influenza-related deaths associated with novel influenza H1N1 are reportable to public health.

Other Advisories:

• Specimen Collection, Processing, and Testing for Patients with Suspected Infection
• Emergency Use Authorization of Medical Products and Devices
• Clinician Guidance on Identifying and Caring for S-OIV Patients
• Clinician Guidance on Prevention and Treatment in Young Children
• Biosafety Guidelines for Lab Workers
• Guidance on Case Definitions for Investigations of Cases
• Guidance for Airlines Regarding Flight Crews Arriving from Areas Affected by S-OIV
• Guidance for Airline Crews in Identifying Passengers Who May Have S-OIV
• Clinician Guidance on Pregnant Women

  • Case Definitions for Investigations of Cases

  • Clinical Data Collection Forms and Templates

  • Infection Control for Patients in a Healthcare Setting

  • Caring for a Sick Person in Your Home

  New tests have been developed to identifty this virus

  Distribution of antivirals and medical supplies has begun to all states

  The vaccine development has begun